nasal spray (NS) was approved by the Food and Drug Administration in 2015 for acute migraine treatment in adolescents ages 12-17 years.
in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
Treatment Clinical trial [reference] options Acute medications Zolmitriptan
Ozkan, "Formulation of zolmitriptan
sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation," European Journal of Pharmaceutics and Biopharmaceutics, vol.
Major Finding: The menstrual migraine recurrence rate 48 hours after treatment with frovatriptan was 15%, significantly less than the collective 26% rate after treatment with rizatriptan, zolmitriptan
, or almotriptan.
gununde bas agrisi ve cift gorme sikayetlerinin azalmasi sonucunda azalan dozlarla oral prednol 0,4 mg/kg (Prednol tablet 16 mg 1x1 0,4 mg/kg) ve Zolmitriptan
(Zomig tablet 2,5 mg 1x1) onerilerek taburcu edildi.
Oksijen inhalasyonu, sumatriptan, dihidroergotamin, zolmitriptan
ve lokal anestetikler suratli ve etkin atak kontrolu saglarlar.
Medications that treat migraines: Anti inflammatories Aspirin (Bayer, Bufferin, Excedrin), ibuprofen (Motrin, Advil), naproxen (Aleve, Nuprin) Triptans Sumatriptan (Imitrex), rizatriptan (Maxalt), zolmitriptan
(Zomig) Ergotamines DHE (dihydroergotamine) nasal spray (Migranal), DHE injection.
, eletriptan) may also lead to serotonin excess, and should be avoided.
In the 6-month follow-up period after the 9-week intervention period, 26 veterans received additional medications for their headaches, usually choline magnesium trisalisylate or another nonsteroidal anti-inflammatory medication to treat tension-like components of headache pain; zolmitriptan
to abort migraine headaches; and an agent such as topirimate, metoprolol, tricyclic antidepressant medication, or divalproex sodium to prevent headaches.
Patients treated three attacks, at least 24 hours apart, with 5 mg or 10 mg of zolmitriptan
nasal spray or placebo, without realizing which treatment they were using.
In a randomised study of 1,380 people with moderate or severe migraine telcagepant was as effective as zolmitriptan
, the most commonly used triptan, and was associated with fewer adverse effects, Dr Tony Ho of Merck Research Laboratories in Philadelphia said in the report.